Cancer Tumor Profiling Market Analysis 2026

Global Cancer Tumor Profiling Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Cancer Tumor Profiling Market Report Description

We have various report editions of Cancer Tumor Profiling Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Cancer Tumor Profiling Market Insights Video

Competitive Landscape of the Cancer Tumor Profiling Market

The competitive landscape of the Cancer Tumor Profiling market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized Cancer Tumor Profiling companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

May 2022: QIAGEN launched the therascreen EGFR Plus RGQ PCR Kit, an innovative in-vitro diagnostic test designed for sensitive EGFR mutation analysis. This test empowers oncologists to improve the treatment guidance for non-small cell lung cancer (NSCLC) patients.

(Source:https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2022/QIAGEN-launches-therascreen-EGFR-Plus-RGQ-PCR-Kit-featuring-C797S-detection-to-help-guide-non-small-cell-lung-cancer-NSCLC-treatment/default.aspx )

January 2022: Illumina formed a partnership with Agendia to enhance next-generation sequencing for decentralized oncology testing. This collaboration is expected to provide improved insights for breast cancer patients worldwide.

(Source:https://www.illumina.com/company/about-us/corporate-social-responsibility/news-feed.html?mid=360911&pgno=17&fdpgno=1 )

Top Companies Market Share in Cancer Tumor Profiling Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Cancer Tumor Profiling Market

Which Region Dominates the Cancer Tumor Profiling Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the region's advanced healthcare infrastructure, significant investments in research and development, and a high prevalence of cancer cases. Additionally, North America boasts a robust network of pharmaceutical and biotechnology companies, along with academic and research institutions, which collectively drive innovation in cancer tumor profiling technologies. Furthermore, favorable government initiatives and policies aimed at promoting precision medicine and personalized cancer treatment have also contributed to the dominance of North America in the global cancer tumor profiling market. These factors have fostered the adoption of advanced diagnostic and therapeutic solutions, thereby propelling market growth in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Cancer Tumor Profiling market due to the rising incidence of cancer across the Asia Pacific region is driving the demand for advanced diagnostic and treatment methods, including tumor profiling. Moreover, increasing awareness about the importance of early detection and personalized treatment options among both healthcare professionals and patients is further fueling the adoption of cancer tumor profiling technologies.

The current report Scope analyzes Cancer Tumor Profiling Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Cancer Tumor Profiling Market Analysis

According to Cognitive Market Research, the global Cancer Tumor Profiling market size was estimated at USD 9915.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 3966.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.8% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Cancer Tumor Profiling market with a market size of USD 3129.24 million in 2024 and is projected to grow at a CAGR of 11.6% during the forecast period. The demand is amplified by the nation's advanced healthcare infrastructure, substantial investment in research and development, and a strong focus on precision medicine initiatives. Additionally, the prevalence of cancer cases in the US and the growing awareness of the benefits of tumor profiling for personalized treatment strategies further drive market growth.
• The Canada Cancer Tumor Profiling market had a market share of USD 475.93 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period.
• The Mexico Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 360.91 million in 2024.

Europe Cancer Tumor Profiling Market Analysis

According to Cognitive Market Research, the global Cancer Tumor Profiling market size was estimated at USD 9915.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 2974.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.1% from 2024 to 2031.

• The United Kingdom Cancer Tumor Profiling market had a market share of USD 499.73 million in 2024 and is projected to grow at a CAGR of 12.9% during the forecast period. The growth of the United Kingdom Cancer Tumor Profiling market is driven by the country's strong emphasis on research and innovation in precision medicine, coupled with robust healthcare infrastructure and increasing awareness about personalized cancer treatment strategies.
• The France Cancer Tumor Profiling market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 273.66 million in 2024.
• According to Cognitive Market Research, the German cancer Tumor Profiling market size was valued at USD 588.96 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period.
• The Italy Cancer Tumor Profiling market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 255.81 million in 2024.
• The Russia Cancer Tumor Profiling market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 461.06 million in 2024.
• The Spain Cancer Tumor Profiling market is projected to witness growth at a CAGR of 11.2% during the forecast period with a market size of USD 243.91 million in 2024
• The Luxembourg Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 92.21 million in 2024.
• The Portugal Cancer Tumor Profiling market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 62.47 million in 2024.
• The Greece Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 35.69 million in 2024.
• Rest of Europe's Cancer Tumor Profiling market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 461.06 million in 2024.

Asia Pacific Cancer Tumor Profiling Market Analysis

According to Cognitive Market Research, the global Cancer Tumor Profiling market size was estimated at USD 9915.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 2280.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2031.

• According to Cognitive Market Research, the China Cancer Tumor Profiling market size was valued at USD 1026.22 million in 2024 and is projected to grow at a CAGR of 15.1% during the forecast period. Cancer Tumor Profiling sales surged in China due to the country's growing healthcare infrastructure, expanding biotechnology and pharmaceutical sectors, and increasing investments in precision medicine research. Additionally, the rising prevalence of cancer cases in China and the government's initiatives to promote early detection and personalized treatment strategies contribute to the surge in Cancer Tumor Profiling sales in the country.
• The Japan Cancer Tumor Profiling market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 314.71 million in 2024.
• The India Cancer Tumor Profiling market had a market share of USD 273.66 million in 2024 and is projected to grow at a CAGR of 17.4% during the forecast period.
• The South Korea Cancer Tumor Profiling market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 228.04 million in 2024.
• The Australia Cancer Tumor Profiling market is projected to witness growth at a CAGR of 15.3% during the forecast period, with a market size of USD 118.59 million in 2024.
• The South East Asia Cancer Tumor Profiling market is projected to witness growth at a CAGR of 16.6% during the forecast period, with a market size of USD 157.35 million in 2024.
• The Rest of Asia Pacific Cancer Tumor Profiling market is projected to witness growth at a CAGR of 15.4% during the forecast period, with a market size of USD 161.92 million in 2024.

South America Cancer Tumor Profiling Market Analysis

According to Cognitive Market Research, the global Cancer Tumor Profiling market size was estimated at USD 9915.2 Million, out of which the Latin America market of more than 5% of the global revenue with a market size of USD 495.76 million in 2024. It will grow at a compound annual growth rate (CAGR) of 13.0% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Cancer Tumor Profiling market size was valued at USD 212.19 million in 2024 and is projected to grow at a CAGR of 13.6% during the forecast period. Cancer Tumor Profiling sales flourish in Brazil due to the country's large population, increasing healthcare investments, and rising incidence of cancer cases.
• Argentina's Cancer Tumor Profiling market had a market share of USD 83.29 million in 2024 and is projected to grow at a CAGR of 13.9% during the forecast period.
• Colombia's Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 44.12 million in 2024.
• Peru Cancer Tumor Profiling market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 40.45 million in 2024.
• Chile's Cancer Tumor Profiling market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 35.69 million in 2024.
• The Rest of Latin America's Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.1% during the forecast period, with a market size of USD 79.82 million in 2024.

Middle East Cancer Tumor Profiling Market Analysis

According to Cognitive Market Research, the global Cancer Tumor Profiling market size was estimated at USD 9915.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 198.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.3% from 2024 to 2031.

• The GCC Countries Cancer Tumor Profiling market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 84.87 million in 2024. The growth of the GCC Countries' Cancer Tumor Profiling market is fueled by the region's increasing healthcare investments, rising prevalence of cancer, and growing adoption of advanced medical technologies.
• The Egypt Cancer Tumor Profiling market is projected to witness growth at a CAGR of 13.6% during the forecast period, with a market size of USD 20.82 million in 2024.
• The South Africa Cancer Tumor Profiling market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 31.33 million in 2024.
• The Turkey Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 17.05 million in 2024.
• The Nigeria Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 20.82 million in 2024.
• The Rest of the MEA Cancer Tumor Profiling market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 23.40 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst at Cognitive Market Research

LinkedIn | Profile | Book Appointment

Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.